SANDOZ DEFERASIROX

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 2781a00c21818173
Drug Approval Canada Name: SANDOZ DEFERASIROX
Product Name: SANDOZ DEFERASIROX
Status: Marketed
Status Date: 2017-07-04
Original Market Date: 2017-07-04
Din: 02464462
Drug Class: Human
Dosage Form: Tablet For Suspension
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 64:00.00
Atc Original: V03AC03 DEFERASIROX
Atc Name: v 03 ac 03
Aig Number: 0151733002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

DEFERASIROX

250 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2781a00c21818173

Type

Standard